Skip to main content
. 2008 Apr 18;14(1):1–21. doi: 10.1093/deafed/enn013

Appendix A:

Demographic information for CI users

ID Sex Age at CI Age at testing Months' experience SES Etiology CI type Processing strategy
CI 1 M 2.58 17.83 183.00 5 Meningitis Nucleus 22 Sprint MPEAK
CI 2 F 2.32 8.16 70.13 3 Unknown Nucleus 22 Sprint ACE
CI 3 F 1.63 9.64 96.10 6 Ushers Nucleus 3G ACE
CI 4 M 2.27 9.25 83.77 4 Heredity, NS Nucleus 22 Sprint ACE
CI 5 M 2.74 14.06 135.90 6 CNX 26 Nucleus 22 Spectra SPEAK
CI 6 M 2.88 16.04 158.03 3 CNX 26 Nucleus 22 Esprit SPEAK
CI 7 M 3.39 16.73 160.07 4 CNX 26 Nucleus 22 Esprit SPEAK
CI 8 M 1.74 7.89 73.73 3 Unknown Nucleus 22 Sprint ACE
CI 9 F 1.59 8.71 85.43 6 Unknown Nucleus 3G ACE
CI 10 M 3.57 15.94 148.53 4 CNX 26 Nucleus 22 Spectra SPEAK
CI 11 F 6.24 13.30 84.70 4 Heredity, NS Nucleus 22 Sprint ACE
CI 12 M 3.34 9.74 76.83 4 Heredity, NS Nucleus 3G ACE
CI 13 F 10.54 15.43 58.63 4 Unknown Nucleus 3G ACE
CI 14 F 3.36 9.44 72.93 4 Unknown Nucleus 22 Sprint ACE
CI 15 M 4.27 8.23 47.50 4 Unknown Nucleus 3G ACE
CI 16 F 3.53 15.92 148.70 5 Unknown Nucleus 22 Esprit SPEAK
CI 17 M 1.64 8.53 82.70 3 Ototoxic Nucleus 3G ACE
CI 18 M 1.48 8.43 83.40 4 Meningitis Nucleus 22 sprint ACE
CI 20 M 5.68 12.81 85.63 4 Unknown Nucleus 3G ACE
CI 21 F 2.27 8.25 71.73 5 CMV infection Nucleus 3G ACE
CI 22 M 2.98 11.99 108.07 3 Coch Mal Nucleus 22 Sprint ACE
CI 23 F 1.61 8.06 77.43 5 Unknown Nucleus 3G ACE
CI 24 M 2.60 10.59 95.93 5 Heredity, NS Nucleus 22 Sprint ACE
CI 25 M 1.69 7.19 66.07 5 Unknown Nucleus 22 Sprint ACE
CI 26 F 10.99 15.13 49.77 4 Unknown Nucleus 3G ACE
CI 27 M 3.82 16.89 156.87 5 Meningitis Nucleus 22 Esprit SPEAK
CI 28 M 3.53 11.85 99.87 3 Coch Mal Nucleus 3G ACE
CI 29 F 2.34 11.40 108.73 3 Heredity, NS Nucleus 3G ACE
Average 3.55 11.88 99.97 4.24
SD 2.39 3.50 36.80 0.95

Note. CI = cochlear implants; CNX 26 = GJBT mutation (Connexin 26); CMV = cytomegalovirus; Coch Mal = cochlear malformation; F = female; Heredity, NS = nonspecific hereditary component; M = male; SES = socioeconomic status.